Becton, Dickinson & Co. (BDX)
157.17
+1.63
(+1.05%)
USD |
NYSE |
Jul 07, 11:50
Becton, Dickinson EPS Diluted (Quarterly) : -1.108 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.108 |
| December 31, 2025 | 1.336 |
| September 30, 2025 | 1.717 |
| June 30, 2025 | 1.998 |
| March 31, 2025 | 1.070 |
| December 31, 2024 | 1.043 |
| September 30, 2024 | 1.449 |
| June 30, 2024 | 1.678 |
| March 31, 2024 | 1.850 |
| December 31, 2023 | 0.9643 |
| September 30, 2023 | 0.369 |
| June 30, 2023 | 1.361 |
| March 31, 2023 | 1.533 |
| December 31, 2022 | 1.703 |
| September 30, 2022 | 0.9247 |
| June 30, 2022 | 1.281 |
| March 31, 2022 | 1.500 |
| December 31, 2021 | 2.284 |
| September 30, 2021 | 0.8385 |
| June 30, 2021 | 1.316 |
| March 31, 2021 | 0.9436 |
| December 31, 2020 | 3.347 |
| September 30, 2020 | 0.358 |
| June 30, 2020 | 0.9714 |
| March 31, 2020 | 0.5272 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.8729 |
| September 30, 2019 | 0.41 |
| June 30, 2019 | 1.51 |
| March 31, 2019 | -0.07 |
| December 31, 2018 | 2.05 |
| September 30, 2018 | -0.64 |
| June 30, 2018 | 2.03 |
| March 31, 2018 | -0.19 |
| December 31, 2017 | -0.76 |
| September 30, 2017 | 1.24 |
| June 30, 2017 | -0.75 |
| March 31, 2017 | 1.58 |
| December 31, 2016 | 2.58 |
| September 30, 2016 | 0.09 |
| June 30, 2016 | 1.794 |
| March 31, 2016 | 1.56 |
| December 31, 2015 | 1.06 |
| September 30, 2015 | 0.84 |
| June 30, 2015 | 0.29 |
| March 31, 2015 | 1.08 |
| December 31, 2014 | 1.20 |
| September 30, 2014 | 1.53 |
| June 30, 2014 | 1.65 |
| March 31, 2014 | 1.45 |
| December 31, 2013 | 1.37 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Boston Scientific Corp. | 0.897 |
| Intuitive Surgical, Inc. | 2.283 |
| Baxter International, Inc. | -0.0291 |
| CONMED Corp. | 0.4516 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.00M |
| Revenue (Quarterly) | 4.714B |
| Total Expenses (Quarterly) | 4.751B |
| Enterprise Value | 59.12B |
| Gross Profit Margin (Quarterly) | 45.69% |
| Profit Margin (Quarterly) | -0.78% |
| Earnings Yield | 2.51% |
| Operating Earnings Yield | 7.27% |
| Normalized Earnings Yield | -1.168 |